Sage Therapeutics Investor Relations Material
Latest events
Q1 2024
Sage Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Sage Therapeutics Inc
Access all reports
Sage Therapeutics, Inc., operates as a biopharmaceutical company, which focuses on the development and commercialization of medicines to treat central nervous system disorders. Its products include, for example, SAGE-547 and SAGE-217.
Key slides for Sage Therapeutics Inc
Q1 2024
Sage Therapeutics Inc
Q1 2024
Sage Therapeutics Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States